Staszewski S - Search Results

1

Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults.

von Hentig N, Dauer B, Haberl A, Klauke S, Lutz T, Staszewski S, Harder S. von Hentig N, et al. Among authors: staszewski s. Eur J Clin Pharmacol. 2007 Oct;63(10):935-40. doi: 10.1007/s00228-007-0344-y. Epub 2007 Jul 31. Eur J Clin Pharmacol. 2007. PMID: 17665183 Clinical Trial.

2

A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.

von Hentig N, Carlebach A, Gute P, Knecht G, Klauke S, Rohrbacher M, Stocker H, Kurowski M, Harder S, Staszewski S, Haberl A. von Hentig N, et al. Among authors: staszewski s. Br J Clin Pharmacol. 2006 Nov;62(5):552-9. doi: 10.1111/j.1365-2125.2006.02664.x. Br J Clin Pharmacol. 2006. PMID: 17061962 Free PMC article.

3

Pharmacokinetics of saquinavir, atazanavir, and ritonavir in a twice-daily boosted double-protease inhibitor regimen.

von Hentig N, Müller A, Rottmann C, Wolf T, Lutz T, Klauke S, Kurowski M, Oertel B, Dauer B, Harder S, Staszewski S. von Hentig N, et al. Among authors: staszewski s. Antimicrob Agents Chemother. 2007 Apr;51(4):1431-9. doi: 10.1128/AAC.00854-06. Epub 2007 Feb 12. Antimicrob Agents Chemother. 2007. PMID: 17296738 Free PMC article.

4

Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1.

Lötsch J, Harder S, Stürmer M, Doerr HW, Geisslinger G, Staszewski S, von Hentig N. Lötsch J, et al. Among authors: staszewski s. Antimicrob Agents Chemother. 2007 Sep;51(9):3264-72. doi: 10.1128/AAC.00036-07. Epub 2007 Jun 18. Antimicrob Agents Chemother. 2007. PMID: 17576836 Free PMC article.

5

The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors.

von Hentig N, Babacan E, Lennemann T, Knecht G, Carlebach A, Harder S, Staszewski S, Haberl A. von Hentig N, et al. Among authors: staszewski s. J Antimicrob Chemother. 2008 Sep;62(3):579-82. doi: 10.1093/jac/dkn204. Epub 2008 May 13. J Antimicrob Chemother. 2008. PMID: 18477709

6

Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.

von Hentig N, Nisius G, Lennemann T, Khaykin P, Stephan C, Babacan E, Staszewski S, Kurowski M, Harder S, Haberl A. von Hentig N, et al. Among authors: staszewski s. Antivir Ther. 2008;13(8):1039-46. Antivir Ther. 2008. PMID: 19195329

7

Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ritonavir.

Stephan C, von Hentig N, Kourbeti I, Dauer B, Mösch M, Lutz T, Klauke S, Harder S, Kurowski M, Staszewski S. Stephan C, et al. Among authors: staszewski s. AIDS. 2004 Feb 20;18(3):503-8. doi: 10.1097/00002030-200402200-00017. AIDS. 2004. PMID: 15090803

8

Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.

Stephan C, Berger A, Carlebach A, Lutz T, Bickel M, Klauke S, Staszewski S, Stuermer M. Stephan C, et al. Among authors: staszewski s. J Antimicrob Chemother. 2005 Dec;56(6):1087-93. doi: 10.1093/jac/dki396. Epub 2005 Nov 3. J Antimicrob Chemother. 2005. PMID: 16269552

9

The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.

Staszewski S, Babacan E, Stephan C, Haberl A, Carlebach A, Gute P, Klauke S, Hermschulte Y, Stuermer M, Dauer B; Frankfurt HIV Cohort. Staszewski S, et al. J Antimicrob Chemother. 2006 Nov;58(5):1024-30. doi: 10.1093/jac/dkl375. Epub 2006 Sep 6. J Antimicrob Chemother. 2006. PMID: 16956902 Clinical Trial.

10

Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.

Stürmer M, Dauer B, Moesch M, Haberl A, Mueller A, Locher L, Knecht G, Hanke N, Doerr HW, Staszewski S. Stürmer M, et al. Among authors: staszewski s. Antivir Ther. 2007;12(1):25-30. doi: 10.1177/135965350701200102. Antivir Ther. 2007. PMID: 17503744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters